Direct-to-consumer advertising of prescription medicines: A systematic review of the evidence from the perspective of the consumer

Journal of Medical Marketing

Volumn 7, Issue 1, 2007, Pages 45-54

  Harker, Michael ^a   Harker, Debra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248665548     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5050060     Document Type: Review

References (44)

1. Huh, J. & Becker, L. B. (2005). Direct-to-consumer prescription drug advertising: Understanding its consequences. Int. J. Advertising 24(4), 441-466.
2. Kotler, P. & Keller, K. L. (2006). Marketing Management, Pearson Prentice Hall, New Jersey.
3. Khan, K. S., Riet, G., Glanville, J., Sowden, A. J. & Kleijnen, J. (eds.) (2001). Undertaking systematic reviews of research on effectiveness. CRD's guidance for those carrying out or commissioning reviews. NHS Centre for Reviews and Dissemination, University of York, York, UK.
4. Gilbody, S., Wilson, P. & Watt, I. (2005). Benefits and harms of direct-to-consumer-advertising: A systematic review. Qual. Safety Healthcare 14, 246-250.
5. Baukus, R. (2004). DTC advertising. J. Health Commun. 9(6), 563-564.
6. White, H. J., Draves, L. P., Soong, R. & Moore, C. (2004). Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market. Int. J. Advertising 23 1), 53-68.
7. Neutel, C. I & Walop, W. (2005). Drug utilization by men and women: Why the difference? Drug Inform. J. 39(3), 299-311.
8. Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L. & Franks, P. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. JAMA 293(16), 1995-2002.
9. Pope, D. (1991). Advertising as a consumer issue: An historical view. J. Soc. Issues 47(1), 41-56.
10. Palmer, C. & Partners (2000). Consistency of restrictions on medicine advertising with the Bill of Rights Act, memorandum to the Advertising Standards Authority, New Zealand, 5th December.
11. Cohen, D., McCubbin, M., Collin, J. & Perodeu, G. (2001). Medications as social phenomena. Health 5, 441-469.
12. Prevention Magazine (2004). Consumer reaction to DTC advertising of prescription medicines - 7th Survey, New York.
13. Hoek, J., Gendall, P. & Calfee, J. (2004). Direct-to-consumer-advertising of prescription medicines in the United States and New Zealand: An analysis of regulatory approaches and consumer responses. Int. J. Advertising 23(2), 197-227.
14. Berndt, E. R. (2005). The United States' experience with direct-consumer advertising of prescription drugs: What have we learned, Paper presented at the International Conference on Pharmaceutical Innovation, Institute of Economics, Academia Sinica, Grand Hotel, Taipei, Taiwan, May 25-27, Session B4, 'Consumerism and the Demand for Pharmaceuticals'.
15. The Advisory Commission on Consumer Protection and Quality in the Health Care Industry. (1998). Quality first: Better healthcare for all Americans. Available from http://www.hcqualitycommission.gov/final/ append_a.html accessed 9th October 2006.
16. Aikin, K. J., Swasey, J. L. & Braman, A. C. (2004). Patients and physicians attitudes and behaviors associated with DTC promotion of prescription drugs - summary of FDA survey results. FDA, http://www.fda.gov/cder/ddmac/Final%20Report/
17. ORC International. (2002). Effectiveness of and attitudes toward medication advertising, Consultancy report prepared for NCL.
18. Deshpande, A. D., Menon, A., Perri III, M. & Zinkhan, G. M. (2004). Direct to consumer advertising and its utility in healthcare decision making. J. Healthcare Commun. 9, 499-513.
19. Huh, J. & Cude, B. J. (2004). Is the information 'fair and balanced' in direct-to-consumer prescription drug websites? J. Healthcare Commun. 9, 529-540.
20. Anantharaman, R., Anju, P. & Shepherd, M. (2005). Examination of the relationship between direct-to-consumer-advertising expenditure and price. Drug Inform. J.. http://findarticles.com/p/articles/ mi_qa3899/is_200501/ai_n13602163 accessed 9th October 2006.
21. Auton, F. (2004). The advertising of pharmaceuticals direct-to-consumers: A critical review of the literature and debate. Int. J. Advertising 23(1), 5-52.
22. United States General Accounting Office (2002). Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. United States General Accounting Office, Washington DC.
23. Kahn, C. (2001). How the media influences women's' perceptions of healthcare. Market. Health Serv. 21(1), 13-17.
24. Calfee, J. E. (2002). Public policy issues in the direct to consumer advertising of prescription drugs. J. Public Policy Market. 21 2), 174-193.
25. Lexchin, J. & Mintzes, B. (2002). Direct-to-consumer-advertising of prescription drugs: The evidence says no. J. Public Policy Market. 21(2), 194-202.
26. Swann, N. (2005). Direct-to-consumer-advertising of prescription medication. The Health Report, Radio National, Australia.
27. Choudry, N. K., Fletcher, R. H. & Soumerai, S. B. (2005). Systematic review: The relationship between clinical experience and quality healthcare. Ann. Int. Med. 142(4), 260-273.
28. Creswell, A. (2006). Unis producing doctors trained as social workers. The Australian, May 9, p. 8.
29. Gallagher, T. H. & Levinson, W. (2004). A prescription for protecting the doctor - patient relationship. Am. J. Manag. Care 10 (2), 61-68.
30. Weissman, J. S., Blumenthal, D., Silk, A., Zapert, K., Newman, M. & Leitmann, R. (2003). Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs. Feb 26, available at http://content.healthaffairs.org/cgi/reprint/
31. Bonaccorso, S. N. & Sturchio, J. L. (2002). Direct-to-consumer-advertising is medicalising normal human experience. Br. Med. J. 324(7432), 910-911.
32. AusDiab study on obesity and diabetes. (2006). Study commissioned by the International Diabetes Institute reported in The Australian, 15th May, 2006.
33. Mintzes, B. (2002). For and against: Direct-to-consumer-advertising is medicalising normal human experience. Br. Med. J. 324 (7432), 908-909.
34. Costa, C. (2005). Health, the Australian, September 17.
35. Schneemann, K. (2005). Far-fetched conclusions taint views on wider medical profession. Health 23. The Australian, 1-2 October.
36. Conrad, P. & Leiter, V. (2004). Medicalisation, markets and consumers. J. Health Social Behav. 45, 158-176.
37. Eagle, L. & Chamberlain, K. (2004). Prescription medication advertising: professional discomfort and potential patient benefits - can the two be balanced? Int. J. Advertising 23(1), 69-90.
38. Wazana, A. (2000). Antidepressant puts newborns at risk, study says. National Post, 7th May, A2.
39. Koch, Y. D., Ernst, M. E. & Kelly, M. W. (2002). Patients' perceptions about drug advertising and prescription to non-prescription switching. Am. J. Health Syst. Pharm. 59(16), 1568.
40. Reast, J. D., Palihawadana, D. & Spicket-Jones, G. (2004). UK physicians' attitudes towards direct-to-consumer-advertising of prescription drugs. Int. J. Advertising 23(2), 229-252.
41. Vatjanapukka, V. & Warszak, R. (2004). Relationship between consumer knowledge, prescription drug advertising exposure and attitudes to direct-to-consumer prescription advertising. Int. J. Med. Market. 4(4), 350-360.
42. Miller, M. & Waller, S. (2004). Attitudes towards DTC advertising in Australia: An exploratory study. Int. J. Advertising 23, 389-405.
43. Mintzies, B., Barer, M. L., Kravitz, R. L., Bassett, K., Lexchin, J., Kanzanjian, A., Evans, R., Pan, R. & Marion, S. A. (2003). How does direct-to-consumer-advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Med. Assoc. J. 169(5), 405-412.
44. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G. & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New Engl. J. Med. 346(7), 489-505.